THERAVANCE INC - CORPORATE OBLIG

CUSIP: 88338TAB0

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Debt / CORPORATE OBLIG
Market price (% of par)
94.92%
Total 13F principal
$236,692,000
Principal change
+$8,952,000
Total reported market value
$224,829,000
Number of holders
28
Value change
+$9,740,981
Number of buys
14
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 88338TAB0?
CUSIP 88338TAB0 identifies 88338TAB0 - THERAVANCE INC - CORPORATE OBLIG in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - CORPORATE OBLIG as of Q1 2017

As of 31 Mar 2017, THERAVANCE INC - CORPORATE OBLIG was held by 28 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $236,692,000 in principal (par value) of the bond. The largest 10 bondholders included CNH PARTNERS LLC, OAKTREE CAPITAL MANAGEMENT LP, GLG LLC, DEUTSCHE BANK AG\, BAUPOST GROUP LLC/MA, Castle Creek Arbitrage, LLC, LAZARD ASSET MANAGEMENT LLC, PIONEER INVESTMENT MANAGEMENT INC, ADVENT CAPITAL MANAGEMENT /DE/, and Kamunting Street Capital Management, L.P.. This page lists 28 institutional bondholders reporting positions for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.